LFMDP

1 BTC

=

- USD

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock logo

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

LFMDP🇺🇸
0.00032371
0.38%

As of May 30, 2026 at 09:50 UTC

Chart

About LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Website
lifemd.com
Headquarters
NEW YORK
Employees (FY)
384
Listed
2021-10-05
FIGI
-

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

Market Statistics

Market Capâ‚¿ 453.19
24h Volumeâ‚¿ 0.4207
24h Change0.38%
7d Change3.97%
1m Change1.94%

Trading Metrics

Trading Volume (BTC)â‚¿ 0.4207

How to Buy LFMDP

1

Create Your Account

Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.

2

Start Your Trade

From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.

3

Buy LFMDP

Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.

New to Tokenized Assets? Learn more in our Help Center.

Latest News

5 articles
Benzinga favicon
Benzingawww.benzinga.com

Novo Nordisk launched a subscription program for Wegovy (semaglutide) starting March 31, 2026, offering tiered pricing to reduce costs for self-pay patients. Monthly prices range from $329 to $249 for injections (up to $1,200 annual savings) and $289 to $249 for oral versions through telehealth partners including Ro, WeightWatchers, and LifeMD, with Hims & Hers and Sesame expected to join later. The program aims to improve treatment adherence and address cost barriers.

Benzinga favicon
Benzingawww.benzinga.com

LifeMD announced a quarterly cash dividend of $0.5546875 per share on its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on April 15, 2026, to shareholders of record as of April 3, 2026.

Related:
Benzinga favicon
Benzingawww.benzinga.com

Novo Nordisk launched its Wegovy weight loss pill in US pharmacies in December 2025 with competitive pricing starting at $149/month for self-pay patients. The pill demonstrated 17% average weight loss versus 3% for placebo. It's available through major retailers including CVS and Costco, as well as telehealth providers. Despite the positive product launch, NVO stock remains down 35.61% over the past year and trades 8.4% below its 200-day moving average.

GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

LifeMD, Inc. announced a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on January 15, 2026. The announcement reflects the company's financial stability as a leading virtual primary care provider.

Related:
Benzinga favicon
Benzingawww.benzinga.com

Novo Nordisk announced a price reduction for Wegovy and Ozempic, offering a $199/month introductory rate for new self-pay patients, and lowering the standard monthly price from $499 to $349 to improve medication accessibility.

1 BTC

=

- USD

Loading market data...